Taiko Pharmaceutical Co Ltd
TSE:4574

Watchlist Manager
Taiko Pharmaceutical Co Ltd Logo
Taiko Pharmaceutical Co Ltd
TSE:4574
Watchlist
Price: 298 JPY -1.65% Market Closed
Market Cap: 15.1B JPY

Intrinsic Value

The intrinsic value of one Taiko Pharmaceutical Co Ltd stock under the Base Case scenario is 236.98 JPY. Compared to the current market price of 298 JPY, Taiko Pharmaceutical Co Ltd is Overvalued by 20%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
236.98 JPY
Overvaluation 20%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Taiko Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Taiko Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Taiko Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Taiko Pharmaceutical Co Ltd.

Explain Valuation
Compare Taiko Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Taiko Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Taiko Pharmaceutical Co Ltd

Current Assets 8B
Cash & Short-Term Investments 4.1B
Receivables 1.7B
Other Current Assets 2.1B
Non-Current Assets 3.7B
PP&E 3.3B
Intangibles 26m
Other Non-Current Assets 411m
Current Liabilities 2.3B
Accounts Payable 347m
Accrued Liabilities 51m
Other Current Liabilities 1.9B
Non-Current Liabilities 1.4B
Long-Term Debt 119m
Other Non-Current Liabilities 1.3B
Efficiency

Free Cash Flow Analysis
Taiko Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Taiko Pharmaceutical Co Ltd

Revenue
5.8B JPY
Cost of Revenue
-2.5B JPY
Gross Profit
3.3B JPY
Operating Expenses
-3.1B JPY
Operating Income
193m JPY
Other Expenses
220m JPY
Net Income
413m JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Taiko Pharmaceutical Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
Operating Margin is Increasing
42/100
Profitability
Score

Taiko Pharmaceutical Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Taiko Pharmaceutical Co Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Short-Term Solvency
90/100
Solvency
Score

Taiko Pharmaceutical Co Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Taiko Pharmaceutical Co Ltd

There are no price targets for Taiko Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Taiko Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Taiko Pharmaceutical Co Ltd stock?

The intrinsic value of one Taiko Pharmaceutical Co Ltd stock under the Base Case scenario is 236.98 JPY.

Is Taiko Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 298 JPY, Taiko Pharmaceutical Co Ltd is Overvalued by 20%.

Back to Top